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Squamous cell carcinoma of the head and neck occurs in approximately 40,000 patients annually in the United States and is often
treated with radiation therapy. Radiological studies are obtained following treatment for head and neck malignancies to assess
for recurrent tumor, posttreatment changes, and associated complications. Radiation treatment creates a diﬃcult clinical picture
for oncologists, head and neck surgeons, neuroradiologists, and neuropathologists. As post-treatment imaging studies are often
discussed at radiology/pathology working conferences, knowledge of the imaging appearance of radiation-associated changes in
the head and neck and the terminology used by neuroradiologists may not only aid in interpretation of the pathologic specimen,
but also assistin communicationswith neuroradiologists and referring clinicians.
1.Introduction
Squamous cell carcinoma of the head and neck is diagnosed
annually in approximately 40,000 patients in the United
States [1]. Radiation therapy is one component of the
treatment forthisdisease. Thistreatment leadstoendothelial
damage and ﬁbrosis, causing impairment of vascular and
lymphaticﬂow [2],producinghypoxic,hypocellular, and hy-
povascular tissue. This tissue is unable to maintain normal
tissue turnover [3, 4] resulting in tissue necrosis, infection,
and ulceration [4–6]. Imaging of the head and neck in
patients treated for malignancy is routinely performed to
evaluate for recurrent tumor and treatment complications
and is complementary to the physical examination. CT ex-
aminations can evaluate the underlying soft tissues and
bony structures, which cannot be visualized on physical
examination.
There are a variety of complications following radiation
treatment to the neck and it is important for neuropathol-
ogists involved with head and neck cancer to be aware of
these complications. This paper reviews treatment-related
changes including osteoradionecrosis of the mandible, hyoid
bone, and skull base, discusses the imaging appearance of
soft tissue ulceration and ﬁstulous tract formation, as well
as intracranial radiation injury and radiation-associated
lesions. Knowledge or the imaging appearance of radiation-
associated changes in the head and neckand the terminology
used by neuroradiologists may aid in interpretation of the
pathologic specimen and will assist in communications with
neuroradiologists, head and neck surgeons, and referring
clinicians.
2.MucosalIrritationandEdema
Within the ﬁrst two weeks of treatment, mucosal irritation
and edema may occur. In the pharynx and larynx, mucositis
and submucosal edema result in prominent mucosal con-
trast enhancement with thickening of the epiglottis and
aryepiglottic folds (Figure 1). Fibrosis and atrophy develop
over many more months and do not normalize even years
after treatment [7].Necrosisofthepharynx and larynx peaks
in the ﬁrst 12 months after treatment, but has been reported
to occur more than 10 years after radiation therapy [8].
3.Osteoradionecrosis
Osteoradionecrosis, a known complication of radiation
therapy for head and neck malignancies [9–11], involves the2 Pathology Research International
Figure 1: Postradiation changes of the oropharynx: Axial postcon-
trastCTdemonstratesmucositisoftheoropharynxcharacterizedby
enhancement (large arrow), and edema/swelling, or the epiglottis
(smallarrow).
destruction of bony structures. The breakdown of collagen
and cellular death overcomes the ability of the aﬀected tissue
to replicate and leads to failure of healing [3, 11]. This
complication is frequently accompanied by infection, partic-
ularly when it occursin the mandible. Synchronous or meta-
chronous lesions can also occur in cancer patients, so it is
important to determine that a lesion is within the radiation
ﬁeld before considering the diagnosis of osteoradionecrosis
[12].
Risks forosteoradionecrosis related to the radiation ther-
apy include total radiation dose, photon energy, brachyther-
apy, ﬁeld size, fractionation [13]. Osteoradionecrosis is
unlikely to occur if the radiation dose is below 60Gy, deliv-
ered by standard fractions [14], but has a higher likelihood
of occurrence if the dose is higher than 65–75Gy [13].
Other risk factors for the development of osteoradionecrosis
includeperiodontitis, poororalhygiene,alcoholandtobacco
use [15], dental extractions, tumor size, location and stage,
proximity oftumortobone, and preirradiation bone surgery
[13]. Reuther et al. [16] studied 830 head and neck tumor
patients evaluated during a 30-year period and suggested
that tumor stage, inﬁltration of adjacent bone, and tooth
extractions are the most important predisposing factors for
osteoradionecrosis.
A study by Curi and Lauria [17] demonstrates that oral
cancers showed the highest incidence of osteoradionecrosis.
Seventy-eight percent of occurrences involved the tongue,
retromolar trigone, and ﬂoor of mouth. This may be related
toinvolvementofthemandibular bonein theradiation ﬁelds
and the aggressive, often radical surgical approach necessary
for tumor resection of these lesions.
The clinical presentation of osteoradionecrosis includes
pain, drainage, and ﬁstula formation between the mucosa
or skin, and related to bone in the radiation ﬁeld. Other
symptoms include otalgia, pain localized to the face, jaw, or
throat. Long-term complication includes dry mouth, loss of
taste, progressive periodontal attachment loss, dental caries,
microvascular alternation, soft tissue necrosis, less com-
monly osteoradionecrosis, and limitation of mouth opening
[13].
3.1. Mandible. Mandibular osteoradionecrosis (ORN) is a
serious complication of radiation therapy for neoplasms of
the oral cavity,oropharynx, nasopharynx, and parotid gland,
with a varying reported incidence of 5% to 22% [9, 11, 18,
19]. The higher incidence of mandibular involvement has
been attributed to its lower blood supply compared with the
maxilla and the compact bone structure [11, 20].
The clinical diagnosis of mandibular osteoradionecrosis
is based on symptoms and signs of ulceration or necrosis of
the overlying mucous membrane with exposure of necrotic
bone [21]. Since a soft-tissue abnormality may be misin-
terpreted as tumor recurrence, correlation should be made
with the typical osseous ﬁndings of mandibular osteora-
dionecrosis on CT scans. These include cortical disruption,
disorganization of trabeculation, and osseous fragmentation
[22]( F i g u r e2). Chong et al. [23]d e m o n s t r a t e dt h a t
enhancement can occur in the soft tissues adjacent to oste-
oradionecrosis; however, identifying the aforementioned
signs of osteoradionecrosis can lead to the correct diagnosis.
Associated with osteoradionecrosis of the mandible may
also be diﬀuse enhancement of the adjacent masseter and
pterygoid muscles, and this should not be confused with
tumor [23].
3.2. Hyoid Bone. The hyoid bone is located inferior to the
oral cavity and oropharynx and above the thyroid cartilage.
Themusculatureoftheﬂoorofthemouthandthetongueare
attached to the hyoid bone, providing assistance in tongue
movement and swallowing. Tumor adjacent to the hyoid
bone before radiation therapy is a factor that should be con-
sidered as putting the hyoid at risk [24] for osteoradionecro-
sis. Findings of hyoid osteoradionecrosis include fragmenta-
tion,corticaldisruption, intraosseous orperi-hyoid air, often
adjacent to a tongue-base ulceration. The absence of obvious
enhancing soft-tissue tumor should suggest hyoid ORN in
the radiated patient [24]( F i g u r e3).
3.3. Skull Base. Osteoradionecrosis of the skull base may be
suggested by destruction of the bone and may be extensive
and symmetric or localized. The most common locations are
the sphenoid bone, followed by the clivus, internal carotid
canal, and temporal bone. Destruction of bone is present
with sequestra present within or surrounding necrotic bone
and small collections of air within the soft tissue adjacent to
the necrotic bone [25]( F i g u r e4). Huang et al. [25]r e p o r t e d
that the pathologic evaluation is very important because
sometimes it is diﬃcult to diﬀerentiate tumor recurrence
from ORN or the two pathologic changes existed at the same
time during the operation.Pathology Research International 3
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Figure 2: Mandibular osteoradionecrosis: (a) Axial contrast-enhanced CT of the mandible (bone window) shows destruction of the
mandible, including along the lingual cortex and loss of the normal trabecular pattern (arrow). (b) Axial contrast-enhanced CT (soft tissue
window) shows no evidence of an enhancing soft tissue mass. Linear enhancement (arrow) represents mucositis.
(a) (b)
Figure 3: Hyoid bone osteoradionecrosis: (a) Axial contrast enhanced CT of the mandible bone (bone window) shows destruction of the
right hyoid bone with soft tissue air (arrow). (b) Axial contrast-enhanced CT (soft tissue window) shows soft tissue ulceration without
evidence of an enhancing soft tissue mass (arrow).
4.Chondronecrosis
4.1. Larynx. The larynx includes the thyroid, arytenoid, and
cricoids cartilages and is involved in speech and swallowing.
Computed tomography can have a role in the evaluation of
patients showing signs of laryngeal edema and/or necrosis
after radiation. The diagnosis of chondronecrosis of the
larynx can be strongly suggested in cases of sloughing of
the arytenoid cartilage, fragmentation and collapse of the
thyroid cartilage, and the presence of gas bubbles around
the cartilage [12]( F i g u r e5). On the other hand, if CT scans
show asymmetric laryngeal tissues in a symptomatic patient,
t h e s eﬁ n d i n g sm a yb eu s e dt ot a r g e tt h eb i o p s yi n t ot h em o s t
suspectarea radiologically,which maybeanenhancingmass,
increasing the speciﬁcity of biopsy ﬁndings [12].
5.SoftTissue Injury
5.1. Ulceration. Ulceration is deﬁned as a defect, or excava-
tion, of the surface of a tissue or organ, which is produced
by the sloughing of inﬂammatory necrotic tissue [26]. As4 Pathology Research International
Figure4:Radiationnecrosisoftheskullbasewithﬁstuloustract:Sagittalcontrast-enhancedCTofthemandiblebone(bonewindow)shows
irregularity of the skull base (smallarrow). In addition, there is a ﬁstulous tract extending towards the oral cavity (large arrow).
(a) (b)
Figure 5: Chondronecrosis of the thyroid cartilage: (a) Axial contrast-enhanced CT of the thyroid cartilage (bone window) shows
destruction of the left side of the cartilage (arrow). (b) Axial contrast-enhanced CT (soft tissue window) shows no evidence of an adjacent
enhancing soft tissue mass (arrow).
most necrosis and many recurrences occur within 2 years
following radiation therapy [26] and the risk of injury
related to radiation necrosis is greatest during the ﬁrst 6–
12 months after radiation therapy [21, 27], time of onset
of the ulceration is usually not helpful in distinguishing
between radiation injury and recurrent tumor. Debnam et
al. [28] studied the imaging ﬁndings of 20 patients with
radiation-associated soft tissue ulcerations. They found that
ulcerations without adjacent enhancement failed to demon-
strate evidence of recurrent tumor, either with biopsy or on
follow-up imaging. This ﬁnding suggests that an ulceration
without adjacent enhancement is likely benign (Figure 6(a)).
When ulcerations demonstrate adjacent enhancement, care-
ful observation is required, if biopsy is not performed, as 4
of 8 ulcerations with adjacent enhancement demonstrated
recurrent tumor (Figure 6(b)), while the other 4 ulcerations
were free of tumor with biopsy or on follow-up imaging.
5.2. Fistula. A ﬁstulous tract is an abnormal pathway be-
tween an internal cavityororgan and the surface ofthe body.
These may be caused by infection, tumor, or radiation. Oro-
cutaneous ﬁstulas (Figure 7) are not common, but intraoral
sinus tracts due to dental infections are common [29]. An
orocutaneous ﬁstula leads to aesthetic problems due to thePathology Research International 5
(a) (b)
Figure 6: Benign and malignant soft tissue ulceration: (a) Axial contrast-enhanced CT of the oral cavity (soft tissue window) shows a
benign ulceration (arrow) without an associated soft tissue mass. (b) Axial contrast-enhanced CT (soft tissue window) shows recurrent
tumor characterized by irregular enhancement alongthe ﬂoor of the ulceration (arrows).
(a) (b)
Figure 7: Orocutaneous ﬁstula: (a, b) Axial contrast-enhanced CT of the oral cavity (soft tissue window) shows an orocutaneous ﬁstula
involving the left nasal ala (arrow) and extending through the maxilla (arrow) towards the oral cavity.
continual leakage of saliva from the oral cavity to the face.
With the presence of an adjacent soft tissue mass, coexisting
tumor cannot be excluded [30].
5.3. Thyroglossal Duct Cyst. Seventy percent of congenital
neck masses are thyroglossal duct cysts [31]. These can occur
anywhere along the course of the thyroglossal duct, usually
at the level of the hyoid bone. Enlargement of pre-existing
thyroglossal duct cysts following radiation therapy has been
reported by Singh et al. [32]. They noted that the enlarged
thyroglossal duct cyst became more ﬂuidlike (Figure 8)a n d
should not be misinterpreted as a tumor. When sonogra-
phyguided biopsy was performed, microscopic evaluation
revealed proteinaceous ﬂuid and histiocytes, and a diagnosis
of a benign cyst was made. The enlargement is believed to
have an inﬂammatory cause and shrinkage or stability of the
cyst suggests resolution of the inﬂammation.
6.TemporalLobe Necrosis
Radiation necrosis to the temporal lobes of the brain
can occur following radiation treatment of head and neck
tumors, notably for lesions of the nasopharynx. The inci-
dence has been reported to be 3% [33]. The earliest sign of
temporal lobe necrosis is cerebral edema, which can be
extensive [34]. Disparity between clinical and radiologic6 Pathology Research International
(a) (b)
Figure8:Enlargingthyroglossalductcyst:(a,b)Axialcontrast-enhancedCTatthelevelofthehyoidbone(softtissuewindow)demonstrates
a thyroglossal duct cyst (arrow) which has enlarged following radiation therapy and is containing more ﬂuid centrally (arrow).
(a) (b)
Figure 9: Temporal lobe radiation necrosis: (a) Axial contrast-enhanced MR examination of the brain demonstrates a peripherally enhanc-
ing focus in the right temporal lobe. (b) Axial fast spin echo T2 sequence shows edema around the focus of radiation necrosis characterized
by signal hyperintensity (arrow).
ﬁndings is noteworthy and highly suggestive of temporal
lobe necrosis, and enhancing lesions can be located in the
gray or white matter [34]. Together with an appropriate
history,apresumptivediagnosiscanbemade,andpathologic
proof in most cases is not required [35]. When treated
early with corticosteroids, patients can make a complete or
near complete recovery with only residual cerebral atrophy
(Figure 9)[ 34].
7.Abscess
Abscess formation after radiation may be related to surgery
or be odontogenic in origin. Abscesses will present as a rim
enhancing ﬂuid collection with a surrounding edema, char-
acterized by soft tissue swelling and reticulation (Figure 10),
and may be associated with osteomyelitis of adjacent bony
structures [36].Pathology Research International 7
Figure 10: Left facial abscess: (a) Axial contrast-enhanced CT (soft
tissue window) shows an abscess (arrow) of the left face. This is
characterized by a peripherally enhancing ﬂuid collection with a
small focus of air and adjacent soft tissue swelling.
Figure 11: Radiation-associated osteosarcoma of the mandible: (a)
Axial contrast-enhanced CT of the mandible (bone window) shows
an osteoid matrix (arrow) within the tumor.
8.Radiation-AssociatedNeoplasm
Sarcomas are a known complication [37, 38]o fr a d i a t i o n
therapy. These lesions arise in 0.035–0.2% of all irradiated
patients [38] and represent less than 5% of all sarcomas [37].
A total dose of 55Gy or above has been reported to increase
the incidence of radiation-associated sarcomas [38]. These
sarcomas may present as an enhancing soft tissue, deﬁned
mass and/or bone destruction (Figure 11).
9.Conclusion
Interpretation of the posttreatment neck can be diﬃcult,
withtheappearancesofcomplicationssometimesmimicking
recurrent tumor. A basic understanding of the ﬁndings
commonly seen after radiation therapy may aid the neuropa-
thologistininterpretingpathologicspecimens.Neuropathol-
ogists will be aided by familiarity with the imaging appear-
ances of the posttreatment neck, including changes to bone
and soft tissue structures and features diﬀerentiating ex-
pected complications from recurrent tumor.
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